ArticleCell death & disease2026

Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51.

Di Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.